MedTrace Logo

Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage

NCT00193674 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2011-08-26

No results posted yet for this study

Summary

The purpose of this clinical study is to demonstrate the shift from inflammatory cytokines to non-inflammatory cytokines in women suffering from habitual abortion treated with dydrogesterone (Duphaston).

Conditions

  • Recurrent Miscarriage

Interventions

DRUG

Dydrogesterone

20 mg/day, oral

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • Abbott Products

    lead INDUSTRY

Principal Investigators

  • Guenter Krause, MD · Abbott Products

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-09-30
Primary Completion
2009-07-31
Completion
2009-07-31

Countries

  • Austria
  • Poland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00193674 on ClinicalTrials.gov